Nonalcoholic fatty liver disease (NAFLD) affects about 25% of the population
Those who received Saxenda 3.0 mg lost an average of 8% of their body weight over 56 weeks, compared to 2.6% in the placebo group
There's also the issue of forgetfulness, which happens a lot, especially with elderly patients
GLP-1 lekovi i metabolizam Pored uticaja na apetit, GLP-1 terapija ima i ire metabolike efekte: poboljava osetljivost na insulin smanjuje nivo glukoze u krvi moe povoljno uticati na masnu jetru doprinosi smanjenju visceralne masti Zbog toga se ovi lekovi ne posmatraju samo kao lekovi za mravljenje, ve i kao terapija metabolikog zdravlja
Is there clinical evidence that semaglutide causes headaches
Zangar RC, Novak RF (1997) Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytes